Targeted delivery of CRISPR/Cas9‐mediated cancer gene therapy via liposome‐templated hydrogel nanoparticles

Z Chen, F Liu, Y Chen, J Liu, X Wang… - Advanced functional …, 2017 - Wiley Online Library
Due to its simplicity, versatility, and high efficiency, the clustered regularly interspaced short
palindromic repeat (CRISPR)/Cas9 technology has emerged as one of the most promising …

Editing the central nervous system through CRISPR/Cas9 systems

A Cota-Coronado, NF Díaz-Martínez… - Frontiers in molecular …, 2019 - frontiersin.org
The translational gap to treatments based on gene therapy has been reduced in recent
years because of improvements in gene editing tools, such as the CRISPR/Cas9 system and …

Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy

AM Moreno, N Palmer, F Alemán, G Chen… - Nature biomedical …, 2019 - nature.com
Protein-based therapeutics can activate the adaptive immune system, leading to the
production of neutralizing antibodies and the clearance of the treated cells mediated by …

Peptide/Cas9 nanostructures for ribonucleoprotein cell membrane transport and gene edition

I Lostalé-Seijo, I Louzao, M Juanes, J Montenegro - Chemical Science, 2017 - pubs.rsc.org
The discovery of RNA guided endonucleases has emerged as one of the most important
tools for gene edition and biotechnology. The selectivity and simplicity of the CRISPR/Cas9 …

[HTML][HTML] Efficient peptide-mediated in vitro delivery of Cas9 RNP

O Gustafsson, J Rädler, S Roudi, T Lehto, M Hällbrink… - Pharmaceutics, 2021 - mdpi.com
The toolbox for genetic engineering has quickly evolved from CRISPR/Cas9 to a myriad of
different gene editors, each with promising properties and enormous clinical potential …

Cyclodextrin-based delivery systems for chemical and genetic drugs: Current status and future

Y Gao, L Sun, C Qiao, Y Liu, Y Wang, R Feng… - Carbohydrate …, 2024 - Elsevier
Cyclodextrins (CDs) are cyclic polysaccharides characterized by their unique hollow
structure, making them highly effective carriers for pharmaceutical agents. CD-based …

[HTML][HTML] Activation of necroptosis by engineered self tumor-derived exosomes loaded with CRISPR/Cas9

D Gulei, I Berindan-Neagoe - Molecular Therapy-Nucleic Acids, 2019 - cell.com
CRISPR/Cas9 has proved its efficiency in vitro, where we now know that this tool can
efficiently target specific parts of the genome. These modifications can be used to generate …

Streamlined Generation of CRISPR/Cas9-Mediated Single-Cell Knockout Clones in Murine Cell Lines

T Hub, A Cornean, K Round, T Fleming… - ACS Pharmacology & …, 2024 - ACS Publications
Clonal cell lines harboring loss-of-function mutations in genes of interest are crucial for
studying the cellular functions of the encoded proteins. Recent advances in genome …

Exploring protein orthogonality in immune space: a case study with AAV and Cas9 orthologs

AM Moreno, N Palmer, F Alemán, G Chen, A Pla… - BioRxiv, 2018 - biorxiv.org
ABSTRACT A major hurdle in protein-based therapeutics is the interaction with the adaptive
immune system, which can lead to neutralization by circulating antibodies and clearance of …

A practical guide to genome editing using targeted nuclease technologies

SN Porter, RM Levine… - Comprehensive …, 2011 - Wiley Online Library
Genome engineering using programmable nucleases is a rapidly evolving technique that
enables precise genetic manipulations within complex genomes. Although this technology …